Ranga Krishnan

10.8k total citations · 2 hit papers
117 papers, 7.6k citations indexed

About

Ranga Krishnan is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Ranga Krishnan has authored 117 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 31 papers in Psychiatry and Mental health and 28 papers in Cognitive Neuroscience. Recurrent topics in Ranga Krishnan's work include Cardiac Health and Mental Health (23 papers), Treatment of Major Depression (18 papers) and Functional Brain Connectivity Studies (17 papers). Ranga Krishnan is often cited by papers focused on Cardiac Health and Mental Health (23 papers), Treatment of Major Depression (18 papers) and Functional Brain Connectivity Studies (17 papers). Ranga Krishnan collaborates with scholars based in United States, Singapore and Canada. Ranga Krishnan's co-authors include Maragatha Kuchibhatla, Michael S. Cuffe, Wei Jiang, Christopher M. O’Connor, Robert M. Califf, Eric J. Christopher, Jonathan Davidson, James R. MacFall, David C. Steffens and James G. Lewis and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Ranga Krishnan

112 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

2005 852 citations Ranga Krishnan et al. profile →
Relationship of Depression to Increased Risk of Mortality and Rehospitalization in Patients With Congestive Heart Failure

2001 737 citations Eric J. Christopher, Maragatha Kuchibhatla et al. Archives of Internal Medicine profile →

Peers

Countries citing papers authored by Ranga Krishnan

Since Specialization

Citations

This map shows the geographic impact of Ranga Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranga Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranga Krishnan more than expected).

Fields of papers citing papers by Ranga Krishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranga Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranga Krishnan. The network helps show where Ranga Krishnan may publish in the future.

Co-authorship network of co-authors of Ranga Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Ranga Krishnan. A scholar is included among the top collaborators of Ranga Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranga Krishnan. Ranga Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current understanding of Cyprinid herpesvirus 2, and prospects in its management 2023 ·Indian Journal of Animal Health ·(unknown), (unknown), D. K. Tripathy, D P Nayak, Jyotirmaya Mohanty, Devika Pillai, (unknown), Ranga Krishnan, (unknown), S. Abdul Majeed, G. Taju, A.S. Sahul Hameed, Pramoda Kumar Sahoo	1
2	Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients 2019 ·Translational Psychiatry ·Sudeepa Bhattacharyya, (unknown), Matthias Arnold, Duan Liu, Chunqiao Luo, Hongjie Zhu, Siamak MahmoudianDehkordi, Drew Neavin, Gregory Louie, Boadie W. Dunlop, Mark A. Frye, Liewei Wang, Richard M. Weinshilboum, Ranga Krishnan, A. John Rush, Rima Kaddurah‐Daouk	62
3	Exposure Therapy With Personalized Real-Time Arousal Detection and Feedback to Alleviate Social Anxiety Symptoms in an Analogue Adult Sample: Pilot Proof-of-Concept Randomized Controlled Trial 2019 ·JMIR Mental Health ·(unknown), Tih-Shih Lee, Yin Bun Cheung, Joanna Ling, (unknown), Leslie Lim, (unknown), Zheng Yang Chin, (unknown), Ranga Krishnan, Cuntai Guan	14
4	Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders 2018 ·Journal of Affective Disorders ·Ahmed T. Ahmed, Mark A. Frye, A. John Rush, Joanna M. Biernacka, W. Edward Craighead, William M. McDonald, William V. Bobo, Patricio Riva‐Posse, Susannah J. Tye, Helen S. Mayberg, Daniel K. Hall‐Flavin, Michelle Skime, G. Douglas Jenkins, Liewei Wang, Ranga Krishnan, Richard M. Weinshilboum, Rima Kaddurah‐Daouk, Boadie W. Dunlop	18
5	Incubating the Research Independence of a Medical Scientist Training Program Graduate 2014 ·Academic Medicine ·Kafui Dzirasa, Ranga Krishnan, R. Sanders Williams	12
6	Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway 2013 ·PLoS ONE ·Hongjie Zhu, Mikhail B. Bogdanov, Stephen H. Boyle, Wayne R. Matson, Swati Sharma, Samantha Matson, Erik Churchill, Oliver Fiehn, A. John Rush, Ranga Krishnan, Eve H. Pickering, Marielle Delnomdedieu, Rima Kaddurah‐Daouk	70
7	Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo 2013 ·Translational Psychiatry ·Rima Kaddurah‐Daouk, Mikhail B. Bogdanov, William R. Wikoff, Hongjie Zhu, (unknown), Erik Churchill, (unknown), A. John Rush, Ranga Krishnan, Eve H. Pickering, Marielle Delnomdedieu, Oliver Fiehn	74
8	Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile 2012 ·Scientific Reports ·Rima Kaddurah‐Daouk, Peixiong Yuan, Stephen H. Boyle, Wayne R. Matson, Zhi Wang, (unknown), Hongjie Zhu, George G. Dougherty, Jeffrey Yao, Guang Chen, Xavier Guitart, Paul J. Carlson, Alexander Neumeister, Carlos A. Zarate, Ranga Krishnan, Husseini K. Manji, Wayne C. Drevets	66
9	Treatment Course With Antidepressant Therapy in Late-Life Depression 2012 ·American Journal of Psychiatry ·Yvette I. Sheline, Brianne M. Disabato, Jennifer A. Hranilovich, Carrie L. Morris, Gina D’Angelo, Carl F. Pieper, Tommaso Toffanin, Warren D. Taylor, James R. MacFall, Consuelo H. Wilkins, Deanna M. Barch, Kathleen A. Welsh‐Bohmer, David C. Steffens, Ranga Krishnan, P. Murali Doraiswamy	69
10	AGTR1 gene variation: Association with depression and frontotemporal morphology 2012 ·Psychiatry Research Neuroimaging ·Warren D. Taylor, (unknown), Douglas R. McQuoid, Martha E. Payne, Ranga Krishnan, James R. MacFall, Allison E. Ashley‐Koch	24
11	Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept 2011 ·Translational Psychiatry ·Rima Kaddurah‐Daouk, (unknown), Wayne R. Matson, Swati Sharma, Samantha Matson, Hongjie Zhu, Mikhail B. Bogdanov, Erik Churchill, Ranga Krishnan, A. John Rush, Eve H. Pickering, Marielle Delnomdedieu	102
12	Plasma Omega-3 Polyunsaturated Fatty Acids and Survival in Patients with Chronic Heart Failure and Major Depressive Disorder 2011 ·Journal of Cardiovascular Translational Research ·(unknown), Wei Jiang, Harry Oken, Mona Fiuzat, Linda K. Shaw, (unknown), Maragatha Kuchibhatla, Rima Kaddurah‐Daouk, David C. Steffens, Rebecca Baillie, Michael S. Cuffe, Ranga Krishnan, Christopher M. O’Connor	29
13	BDNF Val66Met genotype and 6-month remission rates in late-life depression 2010 ·The Pharmacogenomics Journal ·Warren D. Taylor, Douglas R. McQuoid, Allison E. Ashley‐Koch, James R. MacFall, (unknown), Ranga Krishnan, David C. Steffens	45
14	Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure 2010 ·Journal of the American College of Cardiology ·Christopher M. O’Connor, Wei Jiang, Maragatha Kuchibhatla, Susan G. Silva, Michael S. Cuffe, (unknown), (unknown), Wendy Gattis Stough, Rebekka M. Arias, Sarah K. Rivelli, Ranga Krishnan	368
15	Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression 2009 ·Psychiatry Research Neuroimaging ·Talaignair N. Venkatraman, Ranga Krishnan, David C. Steffens, Allen W. Song, Warren D. Taylor	41
16	Schizophrenia is a disorder of higher order hierarchical processing 2009 ·Medical Hypotheses ·Ranga Krishnan, Richard S.E. Keefe, Michael Kraus	19
17	Antidepressant Use, Depression, and Survival in Patients With Heart Failure 2008 ·Archives of Internal Medicine ·Christopher M. O’Connor, Wei Jiang, Maragatha Kuchibhatla, Rajendra H. Mehta, Greg L. Clary, Michael S. Cuffe, Eric J. Christopher, (unknown), Robert M. Califf, Ranga Krishnan	110
18	Effects of antidepressant medication on mortality in patients with congestive heart failure 2002 ·Journal of the American College of Cardiology ·Greg L. Clary, Charles W. Davenport, (unknown), Maragatha Kuchibhatla, Dipen Shah, Christopher M. O’Connor, Ranga Krishnan	0
19	Growth Hormone Response to Growth Hormone Releasing Factor in Alzheimer’s Disease 1989 ·Neuroendocrinology ·Charles B. Nemeroff, Ranga Krishnan, (unknown), James Ritchie, Christopher Clark, Wylie Vale, Jean Rivier, Michael O. Thorner	13
20	A study of depressive typologies using grade of membership analysis 1988 ·Psychological Medicine ·Jonathan Davidson, Max A. Woodbury, Susan Pelton, Ranga Krishnan	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact